Planned interim analysis of phase II study of sorafenib and capecitabine (SorCape) in previously treated metastatic colorectal cancer (mCRC): NCT01471353. This is an ASCO Meeting Abstract from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results